Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR004942)
Formula
SVG example
Hydrolyzation
Reactant Thalidomide Product N-Hydroxythalidomide
Reactant Info Product Info
Metabolic Type Oxidation - Hydrolyzation
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR004921 Thalidomide 2-phthalimidoglutaramic acid Conjugation - Amide Hydrolyation Thalidomide [1], [2]
MR004943 Thalidomide 4-hydroxythalidomide Oxidation - Hydrolyzationn Thalidomide [3]
MR004914 Thalidomide 4-phthalimidoglutaramic acid Conjugation - Amide Hydrolyation Thalidomide [1], [2]
MR004934 Thalidomide 5-Hydroxythalidomide Oxidation - Aromatic hydroxylation Thalidomide [4], [2]
MR004925 Thalidomide Alpha-(o-carboxybenzamido)glutarimide Conjugation - Amide Hydrolyation Thalidomide [1], [2]
MR004937 Thalidomide Cis, trans-5'-Hydroxythalidomide Oxidation - Hydrolyzationn Thalidomide [4], [2]
MR004939 Thalidomide Thalidomide arene oxide Oxidation - Epoxidation Thalidomide [4], [2]
MR004941 Thalidomide Thalidomide-5-O-glucuronide Oxidation - Hydrolyzationn Thalidomide [2]
References
1 Chiral inversion and hydrolysis of thalidomide: mechanisms and catalysis by bases and serum albumin, and chiral stability of teratogenic metabolites
2 Thalidomide metabolism and hydrolysis: mechanisms and implications
3 Metabolism of thalidomide in human microsomes, cloned human cytochrome P-450 isozymes, and Hansen's disease patients. J Biochem Mol Toxicol. 2000;14(3):140-7.
4 Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development. Curr Med Chem. 2009;16(27):3480-675.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.